A Threshold in Anti–EBNA-1 Antibody Titers Distinguishes Salivary EBV Shedders From Nonshedders - Top-Institutions - MDSpire

A Threshold in Anti–EBNA-1 Antibody Titers Distinguishes Salivary EBV Shedders From Nonshedders

  • By

  • João Vitor Mahler

  • Philippe A Bilodeau

  • Monique Anderson

  • Takahisa Mikami

  • Natasha Bobrowski-Khoury

  • Mulan Jiang

  • Huimin Zhu

  • James Nguyen

  • Marcelo Matiello

  • Michael Levy

  • Kjetil Bjornevik

  • Natalia Drosu

  • January 6, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Virology

  • #2

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Neurology

  • #3

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Virology

  • #4

    University of Cambridge, Department of Medicine
    University of Cambridge, Department of Medicine

    Cambridge, UK

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Virology

  • #5

    University of Oxford, Nuffield Department of Medicine
    University of Oxford, Nuffield Department of Medicine

    Oxford, UK

    Key Differentiators

    • Immunology
    • Virology
    • Infectious Diseases

Original Source(s)

A Threshold in Anti–EBNA-1 Antibody Titers Distinguishes Salivary EBV Shedders From Nonshedders

  • by João Vitor Mahler, Philippe A Bilodeau, Monique Anderson, Takahisa Mikami, Natasha Bobrowski-Khoury, Mulan Jiang, Huimin Zhu, James Nguyen, Marcelo Matiello, Michael Levy, Kjetil Bjornevik, Natalia Drosu

  • January 6, 2026

Related Content

Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness